Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,787 Cr
up ₹1.4 Cr vs Oct 2022
- Stocks held
- 31
- up 2 vs Oct 2022
- Top 10 weight
- 67.4%
- of the portfolio in its ten largest
- Cash & debt
- 0.4%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 13
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In November 2022 it disclosed 31 stocks worth ₹4,787 Cr, up ₹1.4 Cr from Oct 2022. Its largest positions were Sun Pharmaceutical Industries Limited (15.3%), Cipla Limited (8.8%), Dr. Reddy's Laboratories Limited (8.3%); the ten largest together made up 67.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.5% of its equity. Cash and debt stood at 0.4%. Compared with Oct 2022 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
5%
Holds more cash than 5% of peers
Holdings in November 2022
Download CSVEvery line the fund disclosed, with the change against Oct 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 15.30%
- Δ weight
- up 0.42 pts
- Value
- ₹732 Cr
- Δ value
- up ₹20.4 Cr
- Status
- Added
- Weight
- 8.81%
- Δ weight
- down 0.22 pts
- Value
- ₹422 Cr
- Δ value
- down ₹10.3 Cr
- Status
- Trimmed
- Weight
- 8.30%
- Δ weight
- up 0.10 pts
- Value
- ₹397 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 7.20%
- Δ weight
- up 0.63 pts
- Value
- ₹345 Cr
- Δ value
- up ₹30.2 Cr
- Status
- Added
- Weight
- 5.47%
- Δ weight
- up 0.27 pts
- Value
- ₹262 Cr
- Δ value
- up ₹12.8 Cr
- Status
- Added
- Weight
- 5.14%
- Δ weight
- up 1.17 pts
- Value
- ₹246 Cr
- Δ value
- up ₹56.1 Cr
- Status
- Added
- Weight
- 4.63%
- Δ weight
- down 0.34 pts
- Value
- ₹221 Cr
- Δ value
- down ₹16.1 Cr
- Status
- Trimmed
- Weight
- 4.62%
- Δ weight
- down 0.28 pts
- Value
- ₹221 Cr
- Δ value
- down ₹13.3 Cr
- Status
- Trimmed
- Weight
- 4.51%
- Δ weight
- down 0.54 pts
- Value
- ₹216 Cr
- Δ value
- down ₹25.9 Cr
- Status
- Trimmed
- Weight
- 3.42%
- Δ weight
- down 0.52 pts
- Value
- ₹164 Cr
- Δ value
- down ₹24.8 Cr
- Status
- Trimmed
- Weight
- 3.39%
- Δ weight
- up 0.15 pts
- Value
- ₹162 Cr
- Δ value
- up ₹7.1 Cr
- Status
- Added
- Weight
- 3.20%
- Δ weight
- down 0.15 pts
- Value
- ₹153 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 2.96%
- Δ weight
- down 0.17 pts
- Value
- ₹141 Cr
- Δ value
- down ₹8.1 Cr
- Status
- Trimmed
- Weight
- 2.82%
- Δ weight
- up 0.13 pts
- Value
- ₹135 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 2.71%
- Δ weight
- up 0.29 pts
- Value
- ₹130 Cr
- Δ value
- up ₹13.9 Cr
- Status
- Added
- Weight
- 2.66%
- Δ weight
- up 0.05 pts
- Value
- ₹127 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 2.33%
- Δ weight
- down 0.04 pts
- Value
- ₹111 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 2.23%
- Δ weight
- down 0.01 pts
- Value
- ₹107 Cr
- Δ value
- down ₹28 L
- Status
- Held
- Weight
- 1.85%
- Δ weight
- down 0.10 pts
- Value
- ₹88.5 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 1.84%
- Δ weight
- down 0.02 pts
- Value
- ₹88.2 Cr
- Δ value
- down ₹88 L
- Status
- Trimmed
- Weight
- 1.52%
- Δ weight
- up 0.17 pts
- Value
- ₹73 Cr
- Δ value
- up ₹8 Cr
- Status
- Added
- Weight
- 1.27%
- Δ weight
- up 0.13 pts
- Value
- ₹60.8 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 0.83%
- Δ weight
- up 0.02 pts
- Value
- ₹39.7 Cr
- Δ value
- up ₹94 L
- Status
- Added
- Weight
- 0.50%
- Δ weight
- down 0.02 pts
- Value
- ₹24.1 Cr
- Δ value
- down ₹72 L
- Status
- Trimmed
- Weight
- 0.45%
- Δ weight
- up 0.03 pts
- Value
- ₹21.5 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 0.39%
- Δ weight
- up 0.39 pts
- Value
- ₹18.6 Cr
- Δ value
- up ₹18.6 Cr
- Status
- New
- Weight
- 0.36%
- Δ weight
- down 0.05 pts
- Value
- ₹17.3 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.36%
- Δ weight
- down 1.73 pts
- Value
- ₹17 Cr
- Δ value
- down ₹82.6 Cr
- Status
- Trimmed
- Weight
- 0.32%
- Δ weight
- down 0.04 pts
- Value
- ₹15.5 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 0.25%
- Δ weight
- up 0.01 pts
- Value
- ₹11.8 Cr
- Δ value
- up ₹30 L
- Status
- Added
- Weight
- 0.23%
- Δ weight
- up 0.12 pts
- Value
- ₹10.9 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 0.14%
- Δ weight
- up 0.14 pts
- Value
- ₹6.9 Cr
- Δ value
- up ₹6.9 Cr
- Status
- New
What changed, Oct 2022 to Nov 2022
New New positions (2)
- Global Health Limited0.4% · ₹18.6 Cr
- MedPlus Health Services Limited0.1% · ₹6.9 Cr
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹56.1 Cr (+1.17% pts)
- Lupin Limitedup ₹30.2 Cr (+0.63% pts)
- Sun Pharmaceutical Industries Limitedup ₹20.4 Cr (+0.42% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2022, the weight rose most in Healthcare Services (+1.4 pts) and Retailing (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−1.6 pts).
- Healthcare Services18.1% → 19.5%+1.4 pts
- Retailing0.0% → 0.1%new+0.1 pts
- Pharmaceuticals1.4% → 1.5%+0.1 pts
- Pharmaceuticals & Biotechnology80.1% → 78.5%−1.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2019 | Nov 2021 | May 2022 | Aug 2022 | Oct 2022 | Nov 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.5% | 74.9% | 79.9% | 80.6% | 80.1% | 78.5% |
| Healthcare Services | 20.3% | 22.7% | 17.7% | 17.4% | 18.1% | 19.5% |
| Pharmaceuticals | 1.2% | 1.8% | 1.8% | 1.4% | 1.4% | 1.5% |
| Healthcare Equipment & Supplies | — | 0.6% | 0.6% | 0.6% | 0.4% | 0.3% |
| Retailing | — | — | — | — | — | 0.1% |
Allocation in Nov 2022change vs Oct 2022
- Pharmaceuticals & Biotechnology (19)78.5%▼ 1.6 pts
- Healthcare Services (9)19.5%▲ 1.4 pts
- Pharmaceuticals (1)1.5%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2022
0.4%
▼ 1.7 pts vs Oct 2022
- Cash alone
- 0.3%
- cash and net receivables
- A year earlier
- 4.1%
- Nov 2021 · now ▼ 3.7 pts
- Last 12 months
- 0.3% – 2.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.